Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 31.10.2020 at 2:00 PM JST
Settings

Settings

Goto Application

1. WO2020178636 - BACTERIOPHAGE FOR MODULATING INFLAMMATORY BOWEL DISEASE

Publication Number WO/2020/178636
Publication Date 10.09.2020
International Application No. PCT/IB2020/000182
International Filing Date 06.03.2020
IPC
A61K 35/76 2015.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
76Viruses; Subviral particles; Bacteriophages
A61P 31/04 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
CPC
A61K 35/76
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
76Viruses; Subviral particles; Bacteriophages
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
C12N 2795/10121
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2795Bacteriophages
00011Bacteriophages
10011dsDNA Bacteriophages
10111Myoviridae
10121Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N 2795/10132
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2795Bacteriophages
00011Bacteriophages
10011dsDNA Bacteriophages
10111Myoviridae
10132Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N 2795/10221
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2795Bacteriophages
00011Bacteriophages
10011dsDNA Bacteriophages
10211Podoviridae
10221Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N 2795/10232
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2795Bacteriophages
00011Bacteriophages
10011dsDNA Bacteriophages
10211Podoviridae
10232Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Applicants
  • KEIO UNIVERSITY [JP]/[JP]
  • BIOMX LTD. [IL]/[IL]
Inventors
  • HONDA, Kenya
  • ATARASHI, Koji
  • NARUSHIMA, Seiko
  • KHABRA, Efrat
  • BEN DAVID, Hava
  • WEINSTOCK, Eyal
  • MATIUHIN, Yulia
  • ZAK, Naomi
Agents
  • EHRLICH, Gal
Priority Data
62/815,26507.03.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) BACTERIOPHAGE FOR MODULATING INFLAMMATORY BOWEL DISEASE
(FR) BACTÉRIOPHAGE POUR MODULER UNE MALADIE INTESTINALE INFLAMMATOIRE
Abstract
(EN)
Disclosed herein are bacteriophage compositions and therapeutic uses thereof. The disclosure also relates to bacteriophage that are capable of lysing Klebsiella bacterial strains, e.g., strains that are associated with inflammatory bowel disease, and thereby capable of modulating disease.
(FR)
L'invention concerne des compositions bactériophages et leurs utilisations thérapeutiques. L'invention concerne également un bactériophage qui est capable de lyser des souches bactériennes de Klebsiella, par exemple des souches qui sont associées à une maladie intestinale inflammatoire, et ainsi capable de moduler une maladie.
Latest bibliographic data on file with the International Bureau